Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02703779
Title Exploratory Trial to Estimate Proportion of Patients With Tumor Cell Contaminated Leukapheresis Products With and Without Bortezomib With In-vivo Purging - Multiple Myeloma (MM)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Kansas Medical Center
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
The University of Kansas Medical Center Westwood Kansas 66205 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field